ASPIRA WOMEN’S HEALTH INC.
12117 Bee Caves Road, Building III, Suite 100
Austin, Texas 78738
Supplementary information about the 2022 annual meeting of stockholders
to be held i
n a virtual meeting format only, via live webcast,
at 8:00 a.m. Eastern Daylight Time on Thursday,
This statement (this “Supplement”) supplements and amends the definitive proxy statement dated April 29, 2022 (the “Proxy Statement”) of
Aspira Women’s Health Inc.
(the “Company,” “we,” “us” or “our”) furnished to holders of Company common stock, par value $0.001 per share (“Common Stock”), in connection with the solicitation of proxies on behalf of the Company’s board of directors (our “Board”) for the 2022 annual meeting of stockholders (the “Annual Meeting”) scheduled to be held on June 23, 2022, and any adjournment or postponement thereof. The Annual Meeting will be held in a virtual meeting format only, via live webcast, at 8:00 a.m. Eastern Daylight Time on Thursday, June 23, 2022. The record date for the determination of the stockholders who are entitled to vote at the Annual Meeting is the close of business on April 27, 2022, which is the same record date specified in the Proxy Statement. Except as described in this Supplement, the information provided in the Proxy Statement continues to apply. This Supplement is being filed with the Securities and Exchange Commission and is being made available to our stockholders on June 7, 2022.
The Proxy Statement contains important additional information, and this Supplement should be read in conjunction with it.
REMOVAL OF PROPOSAL THREE REGARDING APPROVAL OF
AN amendment to the Vermillion, Inc. 2019 Stock Incentive Plan
FROM STOCKHOLDER CONSIDERATION
On June 6, 2022, our Board determined not to seek stockholder approval at the Annual Meeting of Proposal Three regarding an amendment to the Vermillion, Inc. 2019 Stock Incentive Plan (the “2019 Plan”), which would (i) change the name of the 2019 Plan to the “Aspira Women’s Health Inc. 2019 Stock Incentive Plan” and (ii) effectuate an increase in the number of shares of Common Stock authorized to be granted under the 2019 Plan by 8,000,000 shares (from 10,492,283 to 18,492,283). Accordingly, we are no longer proposing to modify the 2019 Plan as set forth in Proposal Three, and Proposal Three has been removed from the agenda for the Annual Meeting and will not be considered or voted on at the Annual Meeting. All other proposals presented in the Proxy Statement remain on the agenda for the Annual Meeting and will be considered and voted on at the Annual Meeting as set forth in the Proxy Statement.
Although our Board believes that Proposal Three was appropriately proposed by us, upon further review and careful consideration of various marketplace factors and the views of Company management and the Company’s advisors, our Board has determined that it is in the best interest of the Company and our stockholders to remove Proposal Three from stockholder consideration at the Annual Meeting.
In light of the removal of Proposal Three from consideration at the Annual Meeting, we note to our stockholders the following important matters regarding voting:
Your votes regarding the remaining proposals are important. Please vote on these proposals as described in the Proxy Statement.
ADDITIONAL INFORMATION AND WHERE TO FIND IT
In connection with the Annual Meeting, we filed the Proxy Statement with the Securities and Exchange Commission on April 29, 2022, and, on or about May 13, 2022, we commenced mailing our notice of internet availability of proxy materials, which serves to notify our stockholders that the Proxy Statement, its related proxy card, a notice of meeting and our Annual Report on Form 10-K for the year ended December 31, 2021 are available to them over the Internet unless otherwise instructed by the stockholder. Before making any voting decision, stockholders are urged to read the Proxy Statement and all of the related proxy materials carefully. Copies of the proxy materials, including the Proxy Statement and our Annual Report on Form 10-K for the year ended December 31, 2021 are available at
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Vermillion makes a similar move, sign up!
Other recent filings from the company include the following:
Vermillion's President and CEO was just granted 5,000 options - Sept. 1, 2022
Vermillion's General Counsel & Secretary just picked up 26,667 shares - Aug. 30, 2022
Vermillion director just picked up 13,332 shares - Aug. 29, 2022
Vermillion's President & CEO just picked up 66,667 shares - Aug. 29, 2022
Jack W. Schuler Living Trust just provided an update on activist position in Vermillion - Aug. 29, 2022